Novartis Korea launches fund-raising campaign for CML patients
Published: 2006-10-13 06:56:00
Updated: 2006-10-13 06:56:00
Novartis Korea said it has launched a campaign for the fund-raising to support Korean patients with chronic myeloid leukemia (CML) and metastatic gastrointestinal stromal tumors (GIST) as part of its plan to commemorate its successful five-year landing of Glivec in Korea.
The company has alrea...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
